U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036874) titled 'Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma' on June 17.
Brief Summary: This is a single-centre, prospective cohort study. Consecutive patients with compensated liver disease and hepatocellular carcinoma (HCC) for curative-intent treatment will be invited to this study. The study follow-up duration will be five years. The primary outcome is the composite of incident high-risk varices, hepatic decompensation and liver-related mortality. The participants will undergo transient elastography at baseline and then half-yearly post-HCC curative treatment; and oesophagogastroduodenoscopy (OGD) at...